191 related articles for article (PubMed ID: 24886876)
1. Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.
Dzikiewicz-Krawczyk A; Macieja A; Mały E; Januszkiewicz-Lewandowska D; Mosor M; Fichna M; Strauss E; Nowak J
J Hematol Oncol; 2014 Jun; 7():43. PubMed ID: 24886876
[TBL] [Abstract][Full Text] [Related]
2. Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia.
Wang SM; Zeng WX; Wu WS; Sun LL; Yan D
J Gene Med; 2017 Nov; 19(11):353-359. PubMed ID: 28990296
[TBL] [Abstract][Full Text] [Related]
3. A GDF15 3' UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p.
Teng MS; Hsu LA; Juan SH; Lin WC; Lee MC; Su CW; Wu S; Ko YL
PLoS One; 2017; 12(8):e0183187. PubMed ID: 28806401
[TBL] [Abstract][Full Text] [Related]
4. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
[TBL] [Abstract][Full Text] [Related]
5. Rs4846049 Polymorphism at the 3'-UTR of MTHFR Gene: Association with Susceptibility to Childhood Acute Lymphoblastic Leukemia.
Li X; Zhang S; Yu F
Biomed Res Int; 2019; 2019():4631091. PubMed ID: 31737664
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in microRNA target sites of 37 selected cancer-related genes and the risk of cervical cancer.
Mi Y; Wang L; Zong L; Pei M; Lu Q; Huang P
PLoS One; 2014; 9(1):e86061. PubMed ID: 24465869
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
[TBL] [Abstract][Full Text] [Related]
8. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
[TBL] [Abstract][Full Text] [Related]
9. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.
Annuar AA; Ankathil R; Mohd Yunus N; Husin A; Ab Rajab NS; Abdul Aziz AA; Ibrahim MI; Sulong S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):565-571. PubMed ID: 33639675
[TBL] [Abstract][Full Text] [Related]
10. [Association of polymorphisms of KIR2DL4 gene with leukemia among ethnic Hans from southern China].
Chen R; Deng Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):112-115. PubMed ID: 29419875
[TBL] [Abstract][Full Text] [Related]
11. The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
Gutiérrez-Malacatt H; Ayala-Sanchez M; Aquino-Ortega X; Dominguez-Rodriguez J; Martinez-Tovar A; Olarte-Carrillo I; Martinez-Hernandez A; C CC; Orozco L; Cordova EJ
Asian Pac J Cancer Prev; 2016; 17(4):2265-70. PubMed ID: 27221928
[TBL] [Abstract][Full Text] [Related]
12. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
13. Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia.
Wang SM; Zeng WX; Wu WS; Sun LL; Yan D
Leuk Res; 2018 Feb; 65():61-66. PubMed ID: 29306656
[TBL] [Abstract][Full Text] [Related]
14. Identification of miRSNPs associated with the risk of multiple myeloma.
Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
[TBL] [Abstract][Full Text] [Related]
16. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
[TBL] [Abstract][Full Text] [Related]
17. Leukemia patient-derived lymphoblastoid cell lines exhibit increased induction of leukemia-associated transcripts following high-dose irradiation.
Spencer A; Granter N
Exp Hematol; 1999 Sep; 27(9):1397-401. PubMed ID: 10480430
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients.
Vymetalkova V; Pardini B; Rosa F; Jiraskova K; Di Gaetano C; Bendova P; Levy M; Veskrnova V; Buchler T; Vodickova L; Naccarati A; Vodicka P
Carcinogenesis; 2017 Jan; 38(1):28-39. PubMed ID: 27803053
[TBL] [Abstract][Full Text] [Related]
19. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]